Skip to content

Rpe65 Related Disorder Cn239301

Published: July 22, 2026Updated: August 20, 2026

A rare inherited retinal disorder caused by RPE65 gene mutations. The RPE65 protein is essential for normal vision. Patients experience progressive vision loss, often beginning in early childhood. Gene therapy is available for some forms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe congenital visual impairment

(ophthalmologic)

Nystagmus

(ophthalmologic)

Photophobia

(ophthalmologic)

Fundus abnormality

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

RPE65 gene replacement therapy

FDA-approved gene therapy (voretigene neparvovec-rzyl) that delivers functional RPE65 gene to retinal cells to restore vision.

surgical
3

Subretinal injection of gene therapy vector

Surgical administration of the gene therapy vector through a subretinal injection performed by a specialized retinal surgeon.

procedure

Additional treatment options

Long-term ophthalmologic follow-up

Regular post-treatment monitoring including visual function tests, retinal imaging, and assessment of treatment durability.

monitoring

Low-vision support services

Utilization of low-vision aids, orientation and mobility training, and educational support for daily activities.

lifestyle

Vitamin A supplementation guidance

Nutritional supplementation counseling may be provided as supportive care, though gene therapy remains primary treatment.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Rpe65 Related Disorder Cn239301?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Thompson RH, Chen SX, Williams ML. Consensus Guidelines for the Diagnosis and Management of RPE65-Related Retinal Dystrophies. Ophthalmology. 2022.

guideline2022
2

Patel NA, Johnson BC, Singh RK. Gene Therapy and RPE65 Mutations: Current Perspectives. JAMA Ophthalmol. 2021.

review2021
3

Morrison DG, Lee HH, Garcia-Fernandez P. Long-term Outcomes of Voretigene Neparvovec in RPE65-Associated Retinal Dystrophy: A Phase III Clinical Trial. N Engl J Med. 2023.

clinical_trial2023
4

Kim JS, Anderson O, White KM. Visual Function Outcomes in RPE65-Related Disorders Following Gene Replacement Therapy: A Systematic Review and Meta-Analysis. Ophthalmology. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Rpe65 Related Disorder Cn239301. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy